Biocon Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
SYNGENE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Biocon Limited, the promoter entity of Syngene International Limited, has submitted a declaration under SEBI Regulation 31(4) confirming that none of the entities in the Promoter and Promoter Group category, nor any Persons Acting in Concert (PAC), have created any encumbrance — direct or indirect — on their shareholding in Syngene International during the financial year 2025-26 or as of March 31, 2026. The declaration was filed on April 2, 2026, by Rajesh Umakant Shanoy, Company Secretary and Compliance Officer of Biocon Limited. This is a standard annual regulatory compliance filing required under SEBI's Takeover Regulations.
The absence of any promoter share encumbrances is a positive signal for Syngene International, indicating clean promoter holding with no pledge risk. It reduces the risk of share dilution or forced selling by lenders, which is reassuring for existing shareholders.